Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Does anyone have Nader’s full email to Amarex?

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 155271
(Total Views: 507)
Posted On: 11/05/2021 2:49:15 PM
Posted By: fsoalex
Does anyone have Nader’s full email to Amarex? I’d love to see that as well as the antecedent Amarex communication. We are reacting to what amounts to a snippet of a sound bite. Without context, I see four scenarios that might explain Nader’s email. First the 13d scenario, Nader was being pressed for months to announce the BLA. He got mad and even tho he knew the shortcomings of the BLA submission, he wanted the deficient application to go forward. As I said before without the CYA documentation from Amarex, this seems a low probability.
I think more probably, he was told of the deficiencies but was given the impression that the deficiencies could be cured in an amended submission. If I remember correctly the BLA was originally submitted and then about 4 weeks later an amended version was submitted to the FDA. Obviously the resubmission-was also deficient. I think this has a much greater possibility of being applicable.
Another possibility could be that Amarex downplayed or did not fully convey the extent of the deficiencies. Based on this, Nader believed correction of the deficiencies would be easy. A very good possibility, in my opinion. Of course, there is the possibility that Amarex did not understand the holes in its presentation because of staffing changes, shortages,etc.
Finally that Nader understood that the shortage was an 8 by 10 glossy of Charlie Sheehan, and told them submit. So until Amarex provides all of the context to their allegations, everything is conjecture and I have wasted everybody’s time. My apologies. I rarely comment this frequently


(1)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us